BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16647913)

  • 1. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.
    Sherman ME; Sturgeon S; Brinton LA; Potischman N; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD
    Mod Pathol; 1997 Oct; 10(10):963-8. PubMed ID: 9346174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA; Sheehan CE; Kallakury BV; Ross JS; Malfetano J; Paunovich E; Figge J
    Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
    Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
    Cané S; Bignotti E; Bellone S; Palmieri M; De las Casas L; Roman JJ; Pecorelli S; Cannon MJ; O'brien T; Santin AD
    Am J Obstet Gynecol; 2004 Jan; 190(1):60-6. PubMed ID: 14749636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
    Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP
    Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
    Goldstein NS; Uzieblo A
    Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
    McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
    Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
    Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
    Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
    Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
    Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
    Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
    Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
    Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF
    Gynecol Oncol; 1998 Oct; 71(1):59-63. PubMed ID: 9784320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
    Ng JS; Han AC; Edelson MI; Rosenblum NG
    Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.